What side effects do people report with Cagrilintide?

Most often: fatigue, appetite loss, depressive episode.

What else do people take for weight loss?

Ephedrine (100% of 37), Tirzepatide (94% of 206), Tesamorelin (95% of 82), Eca Stack (100% of 28), Retatrutide (92% of 228).

Peptide

Does Cagrilintide help with weight loss?

Q: Does Cagrilintide help with weight loss?

Possibly — but there are few reports. 100% of 7 people who reported on Cagrilintide for weight loss say it improved; 0% noticed no change and 0% say it got worse.

Possibly — but there are few reports. 100% of 7 people who reported on Cagrilintide for weight loss say it improved. 0% noticed no change and 0% say it got worse.

High-risk compound. Not an approved supplement; serious risks and legal restrictions apply. Nothing here is a recommendation to use it.

Weight loss: what users report

100%better7 reports · few reports

7 better0 no change0 worse

What people say about Cagrilintide and weight loss

“Cagri was a game changer for me. I added 1mg and thats been more than enough.”

Read the discussion ↗

“Every needs to be aware of the severe fatigue that shows up for some ppl, for me it almost landed me in a depressive episode.”

Read the discussion ↗

“Also using Cagri / Tirz to cut while weight training 4 x per week and logging calories / macros. Working great for me, I’m maintaining weight but my body composition is changing for the better.”

Read the discussion ↗

“I recently mixed semaglutide with Cagrillintide and it turned murky. I still injected it and it was fine, actually better than fine it worked great.”

Read the discussion ↗

What the research says

AResearch: Strong9 meta-analyses · 15 trials on PubMed

BMJ · 2024

Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis

Conclusion: GLP-1RAs are efficacious in treating adults with type 2 diabetes. Compared with the placebo, tirzepatide was the most effective GLP-1RA drug for glycaemic control by reducing haemoglobin A1c and fasting plasma glucose concentrations. GLP-1RAs also significantly improved weight management for type 2 diabetes, with CagriSema performing the best for weight loss. The results prompt safety concerns for GLP-1RAs, especially with high dose administration, regarding gastrointestinal adverse events.

BMJ · 2026

Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis

Conclusion: Obesity drugs produce variable weight loss at one year, with larger benefits generally accompanied by greater harms and discontinuation. Most agents do not improve quality of life meaningfully and few show cardiovascular benefits. Decisions in clinical practice should consider trade-offs between benefits and harms within the context of shared decision making.

Biomed Pharmacother · 2024

Efficacy and safety of GLP-1RAs for people with obesity: A systematic review based on RCT and Bayesian network meta-analysis

Conclusion: CagrANDsema exerts the best effect for weight loss. In terms of current dose levels, a higher dose gets better weight-loss effects without increasing the risk of adverse events.

Side effects people mention

fatigue 3appetite loss 1depressive episode 1

What else is Cagrilintide used for?

Appetite 100%of 8

Based on few reports — treat as anecdotal. Information only — not medical advice. How we count